Autism Health and Nutrition
Kelly Barnhill, MBA, CN, CCN, discusses nutrition in autism based on recent publications. She outlines research updates on amino acid patterns, probiotics, and dietary interventions, underscoring both what we know and what we don’t know. The speaker discusses the clinical interpretation and application of this research, touching on common nutrient deficiencies before the Q&A.
Prospective Study on Amino Acid Patterns
Dr. Barnhill outlines a 2025 study on amino acid patterns in over 1,200 children (2-8 years) with autism. Researchers found lower levels of glutamine in children with autism and significant differences in several amino acids across groups (2:00). Specifically, the study noted that those with neurological impairment were deficient in amino acids that presented with susceptibility to neurocytotoxicity and oxidative stress, while those with nutritional concerns presented with a different set of issues, pointing more toward metabolic concerns. Barnhill explains that these findings substantiate clinical observations and suggest that specific amino acid imbalances may be related to different manifestations of autism, supporting the use of nutritional therapeutic intervention to balance amino acid levels. The speaker emphasizes that this is the only amino acid study presented in a prospective way that has been published in a reputable journal in the past few years.
Amino Acid Patterns in Children with Autistic Spectrum Disorder: A Preliminary Biochemical Evaluation (Ferraro et al., 2025)
Prospective Study on Probiotic Intervention
The presenter outlines another recent study that speaks to the concerns of effects of probiotic support for children with autism, AD/HD, and children with both diagnoses (AuDHD) (5:50). Children were given a probiotic or a placebo for three months. Researchers saw a significant improvement in hyperactivity and impulsivity in both the autism and ADHD groups. Most notably, the “comfort score” on a quality-of-life instrument showed significant improvement for autistic children. Barnhill notes that, although this is a small study, its findings support clinical observations that probiotics can improve gastrointestinal symptoms and other related issues in children with autism, potentially impacting their quality of life.
Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study (Rojo-Marticella et al., 2025)
Systematic Review of Dietary Intervention and Gut Health
Barnhill examines a systematic narrative review of all articles published between 2000 and 2024 related to autism, dietary interventions, probiotics, and the microbiome. (25-year review) (7:40). The review validated that dietary intervention can improve GI symptoms and gut health for children with autism, which in turn improves their quality of life. Researchers also identified a cycle where sensory processing issues lead to food avoidance (ARFID), which decreases microbiome diversity and increases harmful microbial species, leading to a neuroinflammatory process that affects behavior (9:12). The speaker asserts that this review provides a strong rationale for addressing GI and microbiome concerns as part of a comprehensive care plan for individuals with autism.
Unraveling the Connections: Eating Issues, Microbiome, and Gastrointestinal Symptoms in Autism Spectrum Disorder (Tomaszek et al., 2025)
Bibliometric Analysis of Influential Articles
The speaker highlights another 25-year study that reviewed all publications on microbiome treatment in autism since 2000 to identify the most impactful and cited articles (10:54). This is one of the first in a series of bibliometric analyses. The study identified two landmark publications: a 2013 mouse model study that established the link between the gut microbiome and ASD, and a very early, relatively small study from 25 years ago that showed improvements in both GI symptoms and behavior in a small group of autistic children treated with an oral antibiotic. These two studies, along with many more, laid the groundwork for the growing field of gut-brain research in autism and further validated the clinical utility of targeting gut health.
Influential articles in autism and gut microbiota: bibliometric profile and research trends (Ying et al., 2025)
Systematic Review of Probiotics in Autism
Barnhill discusses a systematic review that analyzed 10 completed and published clinical studies, as well as 18 ongoing clinical trials, on the use of probiotics in autism. (13:47). Reviewers found that probiotics can improve social behaviors, drastically improve GI symptoms, and positively alter the gut microbiome when used appropriately. The presenter emphasizes this paper as a valuable and easily accessible resource for clinicians and parents, as it provides research backing for the use of probiotics in addressing a range of symptoms beyond just GI issues – essentially describing what we’ve learned and why it’s important.
Probiotics in autism spectrum disorders: a systematic review of clinical studies and future directions(Barba-Vila et al., 2025)
Nutrition Reviews Study on Mediterranean Diet
Barnhill notes that we are seeing more and more solid research emerging about how dietary intervention benefits individuals across the board, highlighting that there is no one-size-fits-all approach for any of us and what that means for clinical applications. She outlines a 2025 evaluation of all studies on children (6-16 years) with autism and ADHD, examining responses to nutritional interventions (16:06). The paper concluded that 70% of individuals who followed a Mediterranean diet showed significant improvement in ADHD symptoms. It also noted significant improvements in depression (80%) and anxiety (50%). The speaker states that these results suggest that focusing on a whole, unprocessed Mediterranean-style diet can be a profound and effective intervention for improving neurological and mental health symptoms.
Mediterranean Diet and Mental Health in Children and Adolescents: A Systematic Review (Camprodon-Boadas et al., 2025)
Study on Gluten- and Casein-Free Diet
The speaker outlines another 2025 study that evaluated a 12-week trial involving 80 children (4-10 years), using a strict, prescribed gluten- and casein-free diet in combination with and separate and distinct from a neurodevelopmental physical therapy program (19:28). Barnhill notes that families prepared meals on their own, meaning there was no technical control group. Researchers saw significant gains in gross motor skills and cognitive function only when the diet was combined with the therapy program. The dietary group alone showed no significant changes. This study suggests that a multidisciplinary, holistic approach is key, and that dietary interventions may be more effective when combined with other therapies.
Effect of Therapeutic Diet Along with Special Physiotherapy Program on Gross Motor Development and Cognitive Function in Autistic Children: A Randomized Controlled Trial (Alsayegh et al., 2025)
Review on Ketogenic Diet
A review of all published papers on the ketogenic diet for individuals with autism found that the diet is not appropriate for everyone due to the high heterogeneity of autism. However, Barnhill continues, it does hold great potential for some individuals by reducing bacterial dysbiosis, decreasing pro-inflammatory cytokines, enhancing gut health, and providing a neuroprotective effect via ketone bodies (21:48). Barnhill underscores that while the ketogenic diet can be effective for the right patient, it should only be implemented with professional guidance due to its complexity and potential dangers when applied inappropriately. More research is needed.
Exploring the potential of the ketogenic diet in autism spectrum disorder: metabolic, genetic, and therapeutic insights (Schrickel et al., 2025)
Food, Nutrition, and Autism
The presenter provides a summary article describing our current understanding of nutrition and autism from a societal and cultural perspective. The paper tangentially addresses all the issues that people in the US should be aware of and attuned to, including environmental and food exposures from prenatal to childhood. Barnhill asserts this study is foundational for building an appropriate dietary approach and understanding what barriers might exist (26:16).
Food, nutrition, and autism: from soil to fork (Shepard et al., 2024)
Systematic Review – Food as Medicine
The speaker notes a recent systematic review that addresses the use of dietary intervention and therapeutic nutritional support across various diagnoses (27:57). The authors highlight several publications that support the idea that food can be considered a form of medicine and is increasingly understood as a pharmaceutical component in health and medical diagnoses. Barnhill emphasizes the importance of not viewing food choices and dietary recommendations for autism as “other” to the general population’s nutritional understanding. Culturally, we continue to recognize that our diets are integral to health and need to be taken seriously. She states that “we need to hold autism research and interventions to the same standards.” This study ultimately resolidifies the interconnectedness of the gut and brain by highlighting the impact of microbiome health in the GI system on both the vagal nerve and cognition (31:00).
Nutraceuticals in Psychiatric Disorders: A Systematic Review (Bozzatello et al., 2024)
Clinical interpretation and application
According to the presented information, Barnhill asserts that clinicians should assume that diet matters and that a nutritionist or dietary specialist should be included in care counseling and planning for children and adults with autism (34:40). She underscores the importance of avoiding packaged food products, ensuring fiber and water intake are sufficient, and addressing feeding concerns with care and compassion. She also suggests incorporating family and community into diet changes, meal preparation, and eating habits. The speaker also suggests working with a professional to outline any specialized diets (37:40).
Micronutrients & Therapeutic Support
Barnhill lists common micronutrient deficiencies, including B vitamins, fat-soluble A and D, and Omega-3 fatty acids. She notes that addressing gaps with supplemental support is reasonable and appropriate to meet the minimal needs in the case that someone doesn’t have access to those nutrients via diet (40:30). She cautions viewers about the supplement market, noting that it is not regulated; and suggests consulting with someone well-versed in what’s needed and the efficacy of different brands before the Q&A (44:10).
Kelly Barnhill, MBA, CN, CCN, is the Director of the Nutrition Clinic at The Johnson Center for Child Health and Development. She is a Certified Clinical Nutritionist, with over a decade of experience working with nutrition in children with autism and related disorders. At the Johnson Center, she directs a team of dieticians and nutritionists that has served over 3000 children through this practice. Ms. Barnhill also serves as Chair of ARI’s Board of Directors
In this webinar:
0:00 – Introductions
2:00 – Prospective study on amino acid patterns
5:50 – Prospective Study on Probiotic Intervention
7:40 – Systematic Review of Dietary Intervention and Gut Health
10:54 – Bibliometric Analysis of Influential Articles
13:47 – Systematic Review of Probiotics in Autism
16:06 – Nutrition Reviews Study on Mediterranean Diet
19:28 – Study on Gluten- and Casein- Free Diet
21:48 – Review on Ketogenic Diet
26:16 – Food, Nutrition, and Autism
27:57 – Systematic Review – Food as Medicine
34:40 – Clinical interpretation and application
40:30 – Micronutrients
44:10 – Q&A
Resources
Cited Studies
The aim of this study is to investigate the impact of using probiotics with strains related to dopamine and gamma-aminobutyric acid production on clinical features of autism spectrum disorder (ASD) and/or attention deficit/hyperactivity disorder (ADHD). This randomized, controlled trial involved 38 children with ADHD and 42 children with ASD, aged 5-16 years, who received probiotics (Lactiplantibacillus plantarum and Levilactobacillus brevis 109/cfu/daily) or placebo for 12 weeks. Parent-reported symptoms were assessed using Conners’ 3rd-Ed and the Social Responsiveness Scale Test, 2nd-Ed (SRS-2), and children completed the Conners Continuous Performance Test, 3rd-Ed (CPT 3) or Conners Kiddie CPT, 2nd-Ed (K-CPT 2). Executive functions, quality of life and sleep patterns were also parent-assessed. Intention-to-treat analyses, controlling for sociodemographic and nutritional covariates, revealed no significant inter-group differences in parent-reported or neuropsychological data after the probiotic intervention. However, age-stratified analyses showed improved hyperactivity-impulsivity symptoms in younger children with ASD (Cohen’s d = 1.245) and ADHD (Cohen’s d = 0.692). Intra-group analyses supported these findings in the aforementioned age and intervention group for both diagnoses. An improvement in impulsivity for children with ASD was also observed in the intra-group analysis of the CPT commissions scores (probiotic: p = 0.001, Cohen’s d = -1.216; placebo: p = 0.013, Cohen’s d = -0.721). A better comfort score (quality of life) was shown in children with ASD (probiotic: p = 0.010, Cohen’s d = 0.722; placebo: p = 0.099, Cohen’s d = 0.456). The probiotics used, may improve hyperactivity-impulsivity in children with ASD or/and ADHD and quality of life in children with ASD. Further research is warranted to explore probiotics as an adjunctive therapeutic intervention for NDs.Trial registration: clinicaltrials.gov Identifier: NCT05167110.
It is hypothesized that gut dysbiosis, a typical feature of patients with autism spectrum disorder (ASD), could be involved in the origin of this neurodevelopmental disorder. Therefore, the use of probiotics to restore gastrointestinal (GI) equilibrium might be a promising therapeutic strategy due to its capacity to balance the gut-brain axis and behavioral responses.
Children with autism spectrum disorder (ASD) experience negative effects on their everyday activities due to cognitive and motor disabilities. Physiotherapy treatment plans aim to reduce body structure and function impairments, promote developmental sequence, and facilitate milestones, while gluten-free casein-free (GFCF) diets have been proven effective in improving autism symptoms. So, the purpose of this study was to investigate the effect of a combined GFCF diet and neurodevelopmental (NDT) physical therapy program on the gross motor development and cognition of children with ASDs. Eighty children with ASD were distributed into four groups: A, for diet intervention; B, for physical therapy; C, for combined diet and physical therapy; and D was the control group. The evaluation was performed using gross motor functional measures and Stanford–Binet V5 before and after intervention. Intervention continued for 3 months for the children with ASD in the Jazan region, Kingdom of Saudi Arabia. Group A showed non-significant change for both gross motor (P = 0.89) and cognition (P = 0.53) functions, Groups B and C revealed significant improvement for both gross motor [mean difference (MD) = −12.77, 14.61] and cognition (MD = −14.2, 14.55), respectively, with (P = 0.001), and finally Group D showed no significant change for both gross motor (P = 0.65) and cognition (P = 0.16). Gross motor development and cognitive function of children with ASD significantly improved with the combination of the GFCF diet and NDT physical therapy program, with significant improvement with the NDT physical therapy alone on gross motor development and cognition, while using the GFCF diet alone had no change.
Current treatment approaches for Autism spectrum disorder (ASD) primarily focus on symptom management rather than addressing underlying dysfunctions. The ketogenic diet (KD), a high-fat, low-carbohydrate diet inducing nutritional ketosis, has shown promise in treating epilepsy and may offer therapeutic benefits for ASD by modulating metabolic and neuroprotective pathways. This review examined the potential impact of KD on underlying mechanisms in ASD. While evidence from human studies on underlying mechanisms is limited, animal research has shown a large overlap of mechanisms modulated by KD and dysfunctions in ASD. As such, targeting multiple disrupted pathways at once, KD presents a potential multifaceted treatment approach for ASD. However, more evidence from human studies is needed on the effectiveness of KD in the modulation of underlying dysfunctions in ASD. Additionally, precision medicine approaches could help identify individuals who would benefit most from the intervention, potentially extending its use to other psychiatric conditions with similar metabolic patterns. Consequently, KD interventions might show the potential to induce a drastic paradigm shift in understanding and treating ASD.
Correct nutrition and diet are directly correlated with mental health, functions of the immune system, and gut microbiota composition. Diets with a high content of some nutrients, such as fibers, phytochemicals, and short-chain fatty acids (omega-3 fatty acids), seem to have an anti-inflammatory and protective action on the nervous system. Among nutraceuticals, supplementation of probiotics and omega-3 fatty acids plays a role in improving symptoms of several mental disorders. In this review, we collect data on the efficacy of nutraceuticals in patients with schizophrenia, autism spectrum disorders, major depression, bipolar disorder, and personality disorders. This narrative review aims to provide an overview of recent evidence obtained on this topic, pointing out the direction for future research.
Don't Miss Upcoming Webinars
Sign up to receive webinar updates and special resources from the Autism Research Institute.
Watch Next
Autism and Gastrointestinal Conditions – Research Updates
Mojdeh Mostafavi, MD
Mojdeh Mostafavi, MD, describes gastrointestinal conditions commonly seen in individuals with autism, including gastroesophageal reflux disease (GERD), inflammatory bowel disease…
Co-Occurring Gastrointestinal Issues in Autism Spectrum Disorder
Marvin Natowicz, MD, PhD, Timothy M. Buie, MD
The gastrointestinal comorbidities webcast reviews the diagnostic recognition and management of gastrointestinal comorbidities in autism. — This activity no longer…
The Role of Nutrition and Dietetics in Disorders of Gut-Brain Interaction
Kelly Barnhill, MBA, CN, CCN, Stephen M. Edelson, PhD
Nutrition and dietary factors play an important role in disorders of gut-brain interaction and may contribute to symptoms in individuals…
2026 Research Updates: GI Symptoms & Behavior
Bradley Ferguson, MA, PhD
Dr. Bradley Ferguson, PhD, a 2024 research grant recipient, will share emerging research on the interaction of GI symptoms and behavior in…